MedPath

Improvement of Fluid Balance in Patients Undergoing Surgery of the Colon and Rectum

Phase 4
Completed
Conditions
Colorectal Carcinoma
Interventions
Procedure: Goal-directed fluid optimization
Other: Regimen based on expertise anaesthesist
Registration Number
NCT01175317
Lead Sponsor
Maastricht University Medical Center
Brief Summary

58 patients undergoing surgery of the large bowel are divided into two groups. The control group will receive standard care. The intervention group will receive standard care plus optimization of the blood circulation based on in- or decrease of the output of the heart. Between group differences are measured primarily by markers of intestinal damage in plasma and urine. Also CO2 pressure in the stomach lumen is measured (reflecting blood supply to the gut).

The investigators hypothesize that the intervention group will have less intestinal damage, improved blood supply to the bowel and improved recovery of the operation compared to the control group.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
58
Inclusion Criteria
  • All patients undergoing elective colorectal surgery with anastomosis;
  • Minimum age 18 years;
  • Giving informed consent.
Exclusion Criteria
  • Other causes of intestinal damage: eg. IBD, occlusive disease;
  • Steroid use;
  • Esophageal varices and other esophageal disease;
  • Aortic valve disease.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Goal-directed fluid optimizationGoal-directed fluid optimizationFluid administration and optimization based on cardiac output findings during surgery and during the first 8 hours of the postoperative phase.
Regimen based on expertise anaesthesistRegimen based on expertise anaesthesistFluid regimen based on expertise anaesthesist
Primary Outcome Measures
NameTimeMethod
Peak Value of I-FABP1 hour postoperatively

Intestinal-Fatty Acid Binding Protein (a marker of intestinal damage) is measured in plasma.

The primary outcome measure is the difference in peak values of I-FABP between the control group and the intervention group.

Secondary Outcome Measures
NameTimeMethod
Average Intraoperative CO2 GapAverage intraoperative CO2 gap

The CO2 gap (difference arterial pCO2 and pCO2 of the stomach lumen) reflects global intestinal perfusion status and is measured every 15 minutes intraoperatively and every 60 minutes during the first 8 hours postoperatively.

Intraoperative measurements were averaged per individual patient, producing the average intraoperative CO2 gap.

Trial Locations

Locations (1)

University Hospital Maastricht

🇳🇱

Maastricht, Limburg, Netherlands

© Copyright 2025. All Rights Reserved by MedPath